CAS: 611227-74-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BMS 561392 REF: TR-B596200CAS: 611227-74-8 | - - - | 29,616.00 € | Mon 14 Apr 25 |
 | BMS 561392 REF: 3D-LZA22774CAS: 611227-74-8 | Min. 95% | 1,138.00 €~15,427.00 € | Tue 15 Apr 25 |
 | BMS-561392 REF: TM-T30531CAS: 611227-74-8 | 99.16% | 183.00 €~1,096.00 € | Tue 06 May 25 |
BMS 561392
Controlled ProductCAS:611227-74-8
Formula:
C27H32N4O4
Color and Shape:
Neat
Molecular weight:
476.567
Ref: TR-B596200
| 75mg | 29,616.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
BMS 561392
CAS:611227-74-8
BMS 561392 is an analog inhibitor that has demonstrated potent anticancer activity in human cancer …
Formula:
C27H32N4O4
Purity:
Min. 95%
Molecular weight:
476.6 g/mol
Ref: 3D-LZA22774
| 1mg | 1,138.00 € | ||
| 5mg | 3,214.00 € | ||
| 10mg | 5,143.00 € | ||
| 25mg | 9,642.00 € | ||
| 50mg | 15,427.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
BMS-561392
CAS:611227-74-8
BMS-561392 (DPC333) is a tumor necrosis factor-α ( TNF-α) Invertase inhibitor.
Formula:
C27H32N4O4
Purity:
99.16%
Color and Shape:
Solid
Molecular weight:
476.57
Ref: TM-T30531
| 25mg | 1,096.00 € | ||
| 1mL*10mM (DMSO) | 502.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
